Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis

General anesthetic agents may be associated with the clinical efficacy of electroconvulsive therapy (ECT), as they may influence seizure quality and duration. Hence, a retrospective study was conducted to compare the clinical effects and seizure variables of etomidate and propofol during ECT. Patien...

Full description

Bibliographic Details
Main Authors: In-Young Yoon, Jung-Hee Ryu, Sang-Hwan Do, Beomjun Min, Chang-Hoon Koo
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/7/1023
_version_ 1797590036964704256
author In-Young Yoon
Jung-Hee Ryu
Sang-Hwan Do
Beomjun Min
Chang-Hoon Koo
author_facet In-Young Yoon
Jung-Hee Ryu
Sang-Hwan Do
Beomjun Min
Chang-Hoon Koo
author_sort In-Young Yoon
collection DOAJ
description General anesthetic agents may be associated with the clinical efficacy of electroconvulsive therapy (ECT), as they may influence seizure quality and duration. Hence, a retrospective study was conducted to compare the clinical effects and seizure variables of etomidate and propofol during ECT. Patients treated with ECT under anesthesia with etomidate (n = 43) or propofol (n = 12) were retrospectively analyzed. Seizure variables (seizure duration, intensity, and threshold) and hemodynamic changes during ECT were assessed and recorded. Clinical responses to treatment were evaluated using the Clinical Global Impression scale and mood at discharge after the course of ECT. Adverse effects were also recorded. The demographic characteristics were similar between the two groups. There were no significant differences in the Clinical Global Impression scale scores, mood at discharge, and adverse effects between the two groups (<i>p</i> > 0.05); however, etomidate was associated with a significantly longer motor (42.0 vs. 23.65 s, <i>p</i> < 0.001) and electroencephalogram (51.8 vs. 33.5 s, <i>p</i> < 0.001) seizure duration than propofol. In conclusion, etomidate showed more favorable seizure profiles than propofol during ECT; however, both agents (etomidate and propofol) were associated with similar clinical efficacy profiles at discharge.
first_indexed 2024-03-11T01:14:41Z
format Article
id doaj.art-79648c7f1287438a929a469cd87f1611
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-11T01:14:41Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-79648c7f1287438a929a469cd87f16112023-11-18T18:34:15ZengMDPI AGBrain Sciences2076-34252023-07-01137102310.3390/brainsci13071023Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective AnalysisIn-Young Yoon0Jung-Hee Ryu1Sang-Hwan Do2Beomjun Min3Chang-Hoon Koo4Department of Psychiatry, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaDepartment of Anesthesia and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaDepartment of Anesthesia and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaChung Psychiatric Clinic, Seoul 06614, Republic of KoreaDepartment of Anesthesia and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaGeneral anesthetic agents may be associated with the clinical efficacy of electroconvulsive therapy (ECT), as they may influence seizure quality and duration. Hence, a retrospective study was conducted to compare the clinical effects and seizure variables of etomidate and propofol during ECT. Patients treated with ECT under anesthesia with etomidate (n = 43) or propofol (n = 12) were retrospectively analyzed. Seizure variables (seizure duration, intensity, and threshold) and hemodynamic changes during ECT were assessed and recorded. Clinical responses to treatment were evaluated using the Clinical Global Impression scale and mood at discharge after the course of ECT. Adverse effects were also recorded. The demographic characteristics were similar between the two groups. There were no significant differences in the Clinical Global Impression scale scores, mood at discharge, and adverse effects between the two groups (<i>p</i> > 0.05); however, etomidate was associated with a significantly longer motor (42.0 vs. 23.65 s, <i>p</i> < 0.001) and electroencephalogram (51.8 vs. 33.5 s, <i>p</i> < 0.001) seizure duration than propofol. In conclusion, etomidate showed more favorable seizure profiles than propofol during ECT; however, both agents (etomidate and propofol) were associated with similar clinical efficacy profiles at discharge.https://www.mdpi.com/2076-3425/13/7/1023etomidatepropofolefficacyseizureClinical Global Impression scale
spellingShingle In-Young Yoon
Jung-Hee Ryu
Sang-Hwan Do
Beomjun Min
Chang-Hoon Koo
Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis
Brain Sciences
etomidate
propofol
efficacy
seizure
Clinical Global Impression scale
title Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis
title_full Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis
title_fullStr Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis
title_full_unstemmed Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis
title_short Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment: A Retrospective Analysis
title_sort etomidate versus propofol for electroconvulsive therapy in patients with major depressive disorders in terms of clinical responses to treatment a retrospective analysis
topic etomidate
propofol
efficacy
seizure
Clinical Global Impression scale
url https://www.mdpi.com/2076-3425/13/7/1023
work_keys_str_mv AT inyoungyoon etomidateversuspropofolforelectroconvulsivetherapyinpatientswithmajordepressivedisordersintermsofclinicalresponsestotreatmentaretrospectiveanalysis
AT jungheeryu etomidateversuspropofolforelectroconvulsivetherapyinpatientswithmajordepressivedisordersintermsofclinicalresponsestotreatmentaretrospectiveanalysis
AT sanghwando etomidateversuspropofolforelectroconvulsivetherapyinpatientswithmajordepressivedisordersintermsofclinicalresponsestotreatmentaretrospectiveanalysis
AT beomjunmin etomidateversuspropofolforelectroconvulsivetherapyinpatientswithmajordepressivedisordersintermsofclinicalresponsestotreatmentaretrospectiveanalysis
AT changhoonkoo etomidateversuspropofolforelectroconvulsivetherapyinpatientswithmajordepressivedisordersintermsofclinicalresponsestotreatmentaretrospectiveanalysis